Dimethylamphetamine

ECDD Technical summary
Chemically, dimethylamphetamine is N,N-dimethyl-α-methylbenzeneethanamine; its International Nonproprietary Name is dimetamfetamine. There is no information available on its

pharmacological profile, toxicology, dependence potential, nature and magnitude of associated public health or social problems, or epidemiology of its use and abuse. There is some evidence in rats that the substance is metabolized to methamphetamine and amphetamine. The substance is not under national control in any country, it has no therapeutic use, and there is no information available concerning its production. Trade names exist for the substance, and it is present in a preparation available in the Federal Republic of Germany. There is some evidence of illicit trafficking in this substance in the United States of America. In summary, there is no evidence, except for its structure and the possibility that it could be converted to methamphetamine, that dimethylamphetamine has a pharmacological profile or dependence potential similar to compounds already controlled under the Convention on Psychotropic Substances. Thus, the Expert Committee was unable to make any recommendation until more information becomes available about the compound. In addition, since no significant public health problems have been reported to be associated with dimetamfetamine, no recommendation for urgent control seemed necessary.